Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ajcp/aqaa099 http://scihub22266oqcxt.onion/10.1093/ajcp/aqaa099 32520340!7314266!32520340     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32520340&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Clin+Pathol 2020 ; 154 (2): 142-148 Nephropedia Template TP {{tp|p=32520340|t=2020. Linking Statistics With Testing Policy to Manage COVID-19 in the Community |pdf=|usr=}}{{32520340}} gab.com Text Linking Statistics With Testing Policy to Manage COVID-19 in the Community JO: Am J Clin Pathol http://www.kidney.de/pget.php?&tw=1&pmid=32520340 #FOAvip OBJECTIVES: To determine the public health surveillance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing volume needed, both for acute infection and seroprevalence. METHODS: Required testing volumes were developed using standard statistical methods based on test analytical performance, disease prevalence, desired precision, and population size. RESULTS: Widespread testing for individual health management cannot address surveillance needs. The number of people who must be sampled for public health surveillance and decision making, although not trivial, is potentially in the thousands for any given population or subpopulation, not millions. CONCLUSIONS: While the contributions of diagnostic testing for SARS-CoV-2 have received considerable attention, concerns abound regarding the availability of sufficient testing capacity to meet demand. Different testing goals require different numbers of tests and different testing strategies; testing strategies for national or local disease surveillance, including monitoring of prevalence, receive less attention. Our clinical laboratory and diagnostic infrastructure are capable of incorporating required volumes for many local, regional, and national public health surveillance studies into their current and projected testing capacity. However, testing for surveillance requires careful design and randomization to provide meaningful insights. Twit Text FOAVip Linking Statistics With Testing Policy to Manage COVID-19 in the Community ????Am J Clin Pathol http://www.kidney.de/pget.php?&tw=1&pmid=32520340 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32520340 #FOAvip English Wikipedia <ref>{{Cite pmid|32520340}}</ref> Linking Statistics With Testing Policy to Manage COVID-19 in the Community #MMPMID32520340 Hilborne LH; Wagner Z; Cabreros I; Brook RH Am J Clin Pathol 2020[Jul]; 154 (2): 142-148 PMID32520340show ga OBJECTIVES: To determine the public health surveillance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing volume needed, both for acute infection and seroprevalence. METHODS: Required testing volumes were developed using standard statistical methods based on test analytical performance, disease prevalence, desired precision, and population size. RESULTS: Widespread testing for individual health management cannot address surveillance needs. The number of people who must be sampled for public health surveillance and decision making, although not trivial, is potentially in the thousands for any given population or subpopulation, not millions. CONCLUSIONS: While the contributions of diagnostic testing for SARS-CoV-2 have received considerable attention, concerns abound regarding the availability of sufficient testing capacity to meet demand. Different testing goals require different numbers of tests and different testing strategies; testing strategies for national or local disease surveillance, including monitoring of prevalence, receive less attention. Our clinical laboratory and diagnostic infrastructure are capable of incorporating required volumes for many local, regional, and national public health surveillance studies into their current and projected testing capacity. However, testing for surveillance requires careful design and randomization to provide meaningful insights. |*Clinical Laboratory Techniques/methods/statistics & numerical data[MESH] |*Health Policy[MESH] |*Health Services Accessibility[MESH] |Betacoronavirus/*isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Coronavirus Infections/*diagnosis/epidemiology/prevention & control[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*diagnosis/epidemiology/prevention & control[MESH] |Prevalence[MESH] |Public Health Surveillance/*methods[MESH] |SARS-CoV-2[MESH] |Sensitivity and Specificity[MESH] |Seroepidemiologic Studies[MESH]Linking Statistics With Testing Policy to Manage COVID-19 in the Commu(epmc).pdf DeepDyve Pubget Overpricing